While the top- and bottom-line numbers for Altria (MO) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Altria (MO) came out with quarterly earnings of $1.3 per share, missing the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.29 per share a year ago.
Altria reported lower fourth-quarter profit as cigarette shipment volume declined, dragging down its smokeable product business.
MO's fourth-quarter results are likely to reflect pricing strength and cost discipline, offsetting ongoing cigarette volume pressure.
MO is evaluating non-nicotine and wellness categories through a KT&G collaboration as part of a long-term effort to diversify beyond tobacco.
Get a deeper insight into the potential performance of Altria (MO) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
In the closing of the recent trading day, Altria (MO) stood at $61.91, denoting a +1.44% move from the preceding trading day.
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Altria (MO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Altria stock has risen 8% this year due to analyst optimism regarding its smoke-free products. However, does the surge make it too costly?
MO is making steady progress in the smoke-free transition, with oral nicotine gaining traction as it reshapes the business focus.